"The U.S. Food and Drug Administration today approved Anoro Ellipta (umeclidinium and vilanterol inhalation powder) for the once-daily, long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease ("...
- Patient Information:
Details with Side Effects
No information provided. Please refer to the WARNINGS AND PRECAUTIONS section.
Last reviewed on RxList: 10/15/2012
This monograph has been modified to include the generic and brand name in many instances.
Additional Arcapta Neohaler Information
Report Problems to the Food and Drug Administration
Find out what women really need.